ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
75 hedge funds and large institutions have $12.6M invested in Oncternal Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 17 increasing their positions, 22 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
32% less capital invested
Capital invested by funds: $18.6M → $12.6M (-$5.99M)
Holders
75
Holding in Top 10
–
Calls
$92K
Puts
$115K
Top Buyers
| 1 | +$1.09M | |
| 2 | +$939K | |
| 3 | +$453K | |
| 4 |
E
Ergoteles
New York
|
+$237K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$172K |
Top Sellers
| 1 | -$2.34M | |
| 2 | -$730K | |
| 3 | -$585K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$451K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$346K |